The ERS Annual Congress will feature a scientific program that highlights the latest in respiratory research and clinical practice with symposia and grand rounds focusing on issues of concern both to the respiratory professional and wider public. This year's congress will welcome, for the first time, the inaugural HERMES European examination in pediatric medicine on the Congress opening day. The European conference will also include continuing education courses.
Edward Piper will present on "Phase 2 randomized, double-blind, placebo-controlled study of tralokinumab, an anti-IL-13 monoclonal antibody, in moderate to severe asthma."
Added by MedImmune on February 17, 2011